A Map of Alzheimer's Disease–Signaling Pathways: A Hope for Drug Target Discovery. Issue 5 (20th February 2013)

• Record Type: Journal Article
• Authors: Ogishima, S; Mizuno, S; Kikuchi, M; Miyashita, A; Kuwano, R; Tanaka, H; Nakaya, J
• Is Part Of: Clinical pharmacology & therapeutics. Volume 93:Issue 5(2013)
• Page Start: 399
• Page End: 401
• Publication Date: 2013-02-20
• Subjects: Pharmacology -- Periodicals; Therapeutics -- Periodicals; 615.5
• DOI: 10.1038/clpt.2013.37
• Languages: English
• ISSNs: 0009-9236

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Alzheimer's disease (AD) is a complex neurodegenerative condition, and its drug therapy is challenging. To inform AD drug discovery, we developed the "AlzPathway, " a prototype of a comprehensive map of AD‐related signaling pathways, from information obtained through studies in the public domain. The AlzPathway provides an integrated platform for systems analyses of AD‐signaling pathways and networks.</p> <p> <italic>Clinical Pharmacology &amp; Therapeutics</italic> (2013); <bold>93</bold> 5, 399–401. doi:<ext-link ext-link-type="doi" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">10.1038/clpt.2013.37</ext-link></p> </abstract>